These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25152949)

  • 1. Was there real denervation in the SYMPLICITY HTN-3 trial?
    Ruilope LM
    Eur Heart J; 2014 Jul; 35(26):1699-1700. PubMed ID: 25152949
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistant hypertension and renal denervation. Considerations on the results of the SYMPLICITY HTN-3 trial.
    Ruilope LM; Arribas F
    Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):881-2. PubMed ID: 25242659
    [No Abstract]   [Full Text] [Related]  

  • 3. SYMPLICITY HTN-3 trial: what is it and what does it mean?
    Böhm M; Mahfoud F
    Eur Heart J; 2014 Jul; 35(26):1697-8. PubMed ID: 25152948
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood pressure lowering effect of renal sympathetic denervation or placebo? - building expectations for Symplicity-HTN 3.
    Kjeldsen SE; Narkiewicz K; Oparil S; Hedner T
    Blood Press; 2013 Oct; 22(5):279-81. PubMed ID: 24059787
    [No Abstract]   [Full Text] [Related]  

  • 5. [The Symplicity HTN-3 study].
    Taddei S; Trabattoni D
    G Ital Cardiol (Rome); 2014 Sep; 15(9):460-4. PubMed ID: 25298354
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal denervation in treatment-resistant hypertension - Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials.
    Kjeldsen SE; Narkiewicz K; Oparil S; Hedner T
    Blood Press; 2014 Jun; 23(3):135-7. PubMed ID: 24842262
    [No Abstract]   [Full Text] [Related]  

  • 7. [Position paper on the results of Symplicity HTN-3 trial. Grupo de estudio de la hipertensión arterial resistente].
    Azpiri-López JR; Assad-Morell JL; Ponce de León-Martínez E; Monreal-Puente R; Dávila-Bortoni A; Vázquez-Díaz LA; Treviño-Frutos RJ; Barrera-Oranday F; Del Angel-Soto JG; Martínez JG; Arellano-Torres M
    Arch Cardiol Mex; 2015; 85(2):154-7. PubMed ID: 25700579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal sympathetic denervation in the aftermath of Symplicity HTN-3.
    Kjeldsen SE; Fadl Elmula FE; Persu A; Jin Y; Staessen JA
    Blood Press; 2014 Oct; 23(5):256-61. PubMed ID: 25212427
    [No Abstract]   [Full Text] [Related]  

  • 9. From SYMPLICITY HTN-3 to the renal denervation global registry: where do we stand and where should we go?
    Pathak A; Ewen S; Fajadet J; Honton B; Mahfoud F; Marco J; Schlaich M; Schmieder R; Tsioufis K; Ukena C; Zeller T
    EuroIntervention; 2014 May; 10(1):21-3. PubMed ID: 24832632
    [No Abstract]   [Full Text] [Related]  

  • 10. Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings.
    Esler M
    J Am Soc Hypertens; 2014 Aug; 8(8):593-8. PubMed ID: 25151320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal sympathetic denervation: hypertension therapy and beyond.
    Williams PD; Whitbourn R
    Expert Rev Med Devices; 2013 May; 10(3):329-38. PubMed ID: 23668705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New analysis of the SYMPLICITY HTN-3 trial.
    Mason E; Tofield A
    Eur Heart J; 2015 Mar; 36(9):535. PubMed ID: 25884066
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal nerve ablation after SYMPLICITY HTN-3: confused at the higher level?
    Lüscher TF; Mahfoud F
    Eur Heart J; 2014 Jul; 35(26):1706-11. PubMed ID: 24829361
    [No Abstract]   [Full Text] [Related]  

  • 14. SYMPLICITY: not all that simple.
    Luft FC
    Kidney Int; 2014 May; 85(5):999-1001. PubMed ID: 24786869
    [No Abstract]   [Full Text] [Related]  

  • 15. [Questionable efficacy of renal denervation].
    Mariampillai JE; Fadl Elmula FE; Hoffmann P; Sørensen H; Høieggen A; Kjeldsen SE
    Tidsskr Nor Laegeforen; 2014 Sep; 134(17):1643-4. PubMed ID: 25223668
    [No Abstract]   [Full Text] [Related]  

  • 16. 'SYMPLICITY: not all that simple' is, in fact, simple.
    Meltzer J; Oliver J
    Kidney Int; 2014 Nov; 86(5):1060. PubMed ID: 25360502
    [No Abstract]   [Full Text] [Related]  

  • 17. The complexity after simplicity: how to proceed with renal denervation in hypertension?
    Blankestijn PJ; Alings M; Voskuil M; Grobbee DE
    Eur J Prev Cardiol; 2015 Apr; 22(4):412-4. PubMed ID: 24914028
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal Denervation for Resistant Hypertension.
    Reilly JP; White CJ
    Prog Cardiovasc Dis; 2016; 59(3):295-302. PubMed ID: 27789315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interventional renal sympathetic denervation - a new approach for patients with resistant hypertension].
    Mahfoud F; Böhm M
    Dtsch Med Wochenschr; 2010 Dec; 135(48):2422-5. PubMed ID: 21108158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension: How should data from SYMPLICITY HTN-3 be interpreted?
    Schmieder RE
    Nat Rev Cardiol; 2014 Jul; 11(7):375-6. PubMed ID: 24839974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.